Cerebrospinal fluid and plasma pharmacokinetics of phenobarbital after intravenous administration to patients with status epilepticus

Clinical Drug Investigation

Volumn 14, Issue 4, 1997, Pages 307-313

  Brzakovic B ^a,c   Pokrajac, M ^a   Dzoljic E ^b   Levic Z ^b   Vartigic V M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Faculty of Pharmacy   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; EPILEPTIC STATE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 0030713384     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714040-00009     Document Type: Article

References (16)

1. Coniglio AA, Garnett WR. Status epilepticus. In: Di Piro JT, Talbert RL, Hayes PE, et al., editors. Pharmacotherapy - a pathophysiologic approach. New York: Elsevier, 1989: 599-610
2. Browne TR. The pharmacokinetics of agents used to treat status epilepticus. Neurology 1990; 40: 28-32
3. Bauer J, Elger CE. Management of status epilepticus in adults. CNS Drugs 1994; 1: 26-44
4. Simon RP, Benowitz RH, Copeland J. Influence of the blood-brain pH gradient on brain phenobarbital uptake during status epilepticus. J Pharmacol Exp Ther 1985; 235: 830-5
5. Shaner DM, McCurdy SA, Herring MO, et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988; 38: 202-7
6. Donn SM, Grasela TH, Goldstein GW. Safety of a higher loading dose of phenobarbital in the term newborn. Pediatrics 1985; 75: 1061-4
7. Goldberg MA, McIntyre HB. Barbiturates in the treatment of status epilepticus. Adv Neurol 1983; 34: 499-503
8. Monaco F, Sechi G. The brain distribution of old and new antiepileptic drugs. In: Pisani F, Perucca E, Avanzini G, et al., editors. New antiepileptic drugs (Epilepsy Res, Suppl. 3). New York: Elsevier, 1991: 57-65
9. Bhargava VO. Quantitation of 1-(β-D-glucopyranosil)phenobarbital in plasma and bile. J Chromatogr Biomed Appl 1987; 419: 421-5
10. Nau R, Zysk G, Thiel A, et al. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Eur J Clin Pharmacol 1993; 45: 469-75
11. Sokic DV. Intravenous loading doses of phenobarbitone in the treatment of status epilepticus. Srp Arh Celok Lek 1992; 120: 19-25
12. Butler TC, Mahafee C, Wadell WJ. Phenobarbital: studies of elimination, accumulation, tolerance and dosage schedules. J Pharmacol Exp Ther 1954; 111: 425-35
13. Anderson DM. Phenobarbital. In: John E. Murphy, editor. Clinical pharmacokinetics, Bethesda: ASHP, 1993: 179-92
14. Simon RP, Copeland JR, Benowity NL, et al. Brain phenobarbital uptake during prolonged status epilepticus. J Cereb Blood Flow Metabol 1987; 7: 783-8
15. Waddell WJ, Butler TC. The distribution and excretion of phenobarbital. J Clin Invest 1957; 36: 1217-26
16. Vajda F, Williams FM, Davidson SE, et al. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther 1974; 15: 597-603